Clinical trial
Induction Optimization With Stelara for Crohn's Disease
NCT04629196 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Induction Optimization With Stelara for Crohn's Disease
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 16, 2022
- Completion date
- January 17, 2024
- Enrollment
- 12 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.